BG63074B1 - Лекарства против стрес и функционални храни притежаващи противостресови ефекти - Google Patents
Лекарства против стрес и функционални храни притежаващи противостресови ефекти Download PDFInfo
- Publication number
- BG63074B1 BG63074B1 BG103228A BG10322899A BG63074B1 BG 63074 B1 BG63074 B1 BG 63074B1 BG 103228 A BG103228 A BG 103228A BG 10322899 A BG10322899 A BG 10322899A BG 63074 B1 BG63074 B1 BG 63074B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- stress
- stress agent
- functional food
- fermented yogurt
- fermented
- Prior art date
Links
- 230000002180 anti-stress Effects 0.000 title claims abstract description 61
- 235000013376 functional food Nutrition 0.000 title claims abstract description 23
- 230000000694 effects Effects 0.000 title claims description 16
- 239000003814 drug Substances 0.000 title claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 56
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 235000013618 yogurt Nutrition 0.000 claims abstract description 34
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 25
- 239000004310 lactic acid Substances 0.000 claims abstract description 25
- 241000894006 Bacteria Species 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- 241000186660 Lactobacillus Species 0.000 claims abstract description 5
- 235000013336 milk Nutrition 0.000 claims description 17
- 239000008267 milk Substances 0.000 claims description 17
- 210000004080 milk Anatomy 0.000 claims description 17
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 6
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 6
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 230000037396 body weight Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 235000013351 cheese Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000021067 refined food Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 235000001497 healthy food Nutrition 0.000 claims 1
- 230000003340 mental effect Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 4
- 235000020244 animal milk Nutrition 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 22
- 239000000243 solution Substances 0.000 description 14
- 230000035487 diastolic blood pressure Effects 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- 239000011550 stock solution Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 230000003236 psychic effect Effects 0.000 description 6
- 239000013543 active substance Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000008924 yoghurt drink Nutrition 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002663 nebulization Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 235000014415 Lactobacillus casei subsp casei ATCC 393 Nutrition 0.000 description 1
- 241001640312 Lactobacillus casei subsp. casei ATCC 393 Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241001070017 Lactobacillus fermentum ATCC 14931 Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 244000253911 Saccharomyces fragilis Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000020167 acidified milk Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 230000000342 anti-suppressant effect Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000020252 horse milk Nutrition 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/137—Thickening substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20850496A JP4065038B2 (ja) | 1996-08-07 | 1996-08-07 | 計算作業負荷ストレス緩和剤 |
| PCT/JP1997/002728 WO1998005343A1 (fr) | 1996-08-07 | 1997-08-06 | Medicaments anti-stress et aliments fonctionnels ayant des effets anti-stress |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG103228A BG103228A (en) | 2000-05-31 |
| BG63074B1 true BG63074B1 (bg) | 2001-03-30 |
Family
ID=16557259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103228A BG63074B1 (bg) | 1996-08-07 | 1999-03-05 | Лекарства против стрес и функционални храни притежаващи противостресови ефекти |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6596301B1 (ko) |
| EP (1) | EP0966969B1 (ko) |
| JP (1) | JP4065038B2 (ko) |
| KR (1) | KR100331141B1 (ko) |
| CN (1) | CN1112931C (ko) |
| AR (1) | AR009005A1 (ko) |
| AT (1) | ATE294586T1 (ko) |
| AU (1) | AU719204B2 (ko) |
| BG (1) | BG63074B1 (ko) |
| BR (1) | BR9711126A (ko) |
| CA (1) | CA2262652C (ko) |
| CZ (1) | CZ299912B6 (ko) |
| DE (1) | DE69733215T2 (ko) |
| ES (1) | ES2239784T3 (ko) |
| ID (1) | ID19984A (ko) |
| MX (1) | MXPA99001203A (ko) |
| MY (1) | MY124559A (ko) |
| PT (1) | PT966969E (ko) |
| SK (1) | SK285323B6 (ko) |
| TR (1) | TR199900233T2 (ko) |
| TW (1) | TW445136B (ko) |
| WO (1) | WO1998005343A1 (ko) |
| ZA (1) | ZA976989B (ko) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4727770B2 (ja) * | 1997-09-26 | 2011-07-20 | カルピス株式会社 | 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤 |
| FR2793257B1 (fr) * | 1999-05-06 | 2001-07-27 | Gervais Danone Sa | Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations |
| SE523771C2 (sv) | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
| GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| EP1466529A1 (en) * | 2003-04-07 | 2004-10-13 | Chr. Hansen A/S | Composition with heart rate reducing properties |
| US7718171B2 (en) | 2003-04-07 | 2010-05-18 | Chr. Hansen A/S | Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus |
| US20040265279A1 (en) * | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
| JP4680571B2 (ja) * | 2003-12-25 | 2011-05-11 | カルピス株式会社 | 経口摂取用保湿剤 |
| RU2403051C2 (ru) * | 2004-09-03 | 2010-11-10 | Кр. Хансен А/С | Ферментированное молоко или растительные белки, содержащие рецепторный лиганд, и их применение |
| CN101242849B (zh) * | 2005-06-24 | 2011-07-27 | 卡尔皮斯株式会社 | 表皮细胞分化和角化促进剂、以及用于促进表皮角化的功能性饮料食品 |
| JP2007031309A (ja) * | 2005-07-25 | 2007-02-08 | Tokiwa Yakuhin Kogyo Kk | 抗ストレス組成物 |
| DK1992352T3 (da) | 2006-02-14 | 2014-06-10 | Calpis Co Ltd | Middel til anvendelse i forbyggelsen af aterosklerosis |
| AU2007292786B2 (en) * | 2006-09-04 | 2013-02-14 | Megmilk Snow Brand Co., Ltd. | Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| JP2009046456A (ja) * | 2007-08-23 | 2009-03-05 | Kikkoman Corp | 生殖行動の誘発用組成物 |
| JP2008214253A (ja) | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
| AU2008233633B2 (en) * | 2007-03-30 | 2013-11-14 | Suntory Holdings Limited | Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity |
| US20090022853A1 (en) * | 2007-07-16 | 2009-01-22 | Conopco, Inc., D/B/A Unilever | Beverage |
| US20110195172A1 (en) * | 2008-09-05 | 2011-08-11 | Inge Elisabeth Maria Deutz | Beverages comprising potassium |
| US8273380B1 (en) | 2009-05-19 | 2012-09-25 | Jetway Inc. | Fortified beverage for minimizing and/or preventing jet lag |
| US8975903B2 (en) | 2011-06-09 | 2015-03-10 | Ford Global Technologies, Llc | Proximity switch having learned sensitivity and method therefor |
| US8928336B2 (en) | 2011-06-09 | 2015-01-06 | Ford Global Technologies, Llc | Proximity switch having sensitivity control and method therefor |
| US10004286B2 (en) | 2011-08-08 | 2018-06-26 | Ford Global Technologies, Llc | Glove having conductive ink and method of interacting with proximity sensor |
| US10112556B2 (en) | 2011-11-03 | 2018-10-30 | Ford Global Technologies, Llc | Proximity switch having wrong touch adaptive learning and method |
| US8994228B2 (en) | 2011-11-03 | 2015-03-31 | Ford Global Technologies, Llc | Proximity switch having wrong touch feedback |
| US9568527B2 (en) | 2012-04-11 | 2017-02-14 | Ford Global Technologies, Llc | Proximity switch assembly and activation method having virtual button mode |
| US9197206B2 (en) | 2012-04-11 | 2015-11-24 | Ford Global Technologies, Llc | Proximity switch having differential contact surface |
| US9944237B2 (en) | 2012-04-11 | 2018-04-17 | Ford Global Technologies, Llc | Proximity switch assembly with signal drift rejection and method |
| US9531379B2 (en) | 2012-04-11 | 2016-12-27 | Ford Global Technologies, Llc | Proximity switch assembly having groove between adjacent proximity sensors |
| US9831870B2 (en) | 2012-04-11 | 2017-11-28 | Ford Global Technologies, Llc | Proximity switch assembly and method of tuning same |
| US9520875B2 (en) | 2012-04-11 | 2016-12-13 | Ford Global Technologies, Llc | Pliable proximity switch assembly and activation method |
| US8933708B2 (en) | 2012-04-11 | 2015-01-13 | Ford Global Technologies, Llc | Proximity switch assembly and activation method with exploration mode |
| US9287864B2 (en) | 2012-04-11 | 2016-03-15 | Ford Global Technologies, Llc | Proximity switch assembly and calibration method therefor |
| US9559688B2 (en) | 2012-04-11 | 2017-01-31 | Ford Global Technologies, Llc | Proximity switch assembly having pliable surface and depression |
| US9065447B2 (en) | 2012-04-11 | 2015-06-23 | Ford Global Technologies, Llc | Proximity switch assembly and method having adaptive time delay |
| US9660644B2 (en) | 2012-04-11 | 2017-05-23 | Ford Global Technologies, Llc | Proximity switch assembly and activation method |
| US9219472B2 (en) | 2012-04-11 | 2015-12-22 | Ford Global Technologies, Llc | Proximity switch assembly and activation method using rate monitoring |
| US9184745B2 (en) | 2012-04-11 | 2015-11-10 | Ford Global Technologies, Llc | Proximity switch assembly and method of sensing user input based on signal rate of change |
| US9136840B2 (en) | 2012-05-17 | 2015-09-15 | Ford Global Technologies, Llc | Proximity switch assembly having dynamic tuned threshold |
| US8981602B2 (en) | 2012-05-29 | 2015-03-17 | Ford Global Technologies, Llc | Proximity switch assembly having non-switch contact and method |
| US9337832B2 (en) | 2012-06-06 | 2016-05-10 | Ford Global Technologies, Llc | Proximity switch and method of adjusting sensitivity therefor |
| US9641172B2 (en) | 2012-06-27 | 2017-05-02 | Ford Global Technologies, Llc | Proximity switch assembly having varying size electrode fingers |
| US8922340B2 (en) | 2012-09-11 | 2014-12-30 | Ford Global Technologies, Llc | Proximity switch based door latch release |
| US8796575B2 (en) | 2012-10-31 | 2014-08-05 | Ford Global Technologies, Llc | Proximity switch assembly having ground layer |
| US9311204B2 (en) | 2013-03-13 | 2016-04-12 | Ford Global Technologies, Llc | Proximity interface development system having replicator and method |
| JP6471145B2 (ja) * | 2014-03-04 | 2019-02-13 | アサヒ飲料株式会社 | 鎮静用の自律神経調整剤及び日周リズム改善剤 |
| US10038443B2 (en) | 2014-10-20 | 2018-07-31 | Ford Global Technologies, Llc | Directional proximity switch assembly |
| US9654103B2 (en) | 2015-03-18 | 2017-05-16 | Ford Global Technologies, Llc | Proximity switch assembly having haptic feedback and method |
| US9548733B2 (en) | 2015-05-20 | 2017-01-17 | Ford Global Technologies, Llc | Proximity sensor assembly having interleaved electrode configuration |
| JP6285994B2 (ja) * | 2016-08-09 | 2018-02-28 | 株式会社明治 | シトルリン含有発酵乳およびその製造方法 |
| KR20180019474A (ko) * | 2016-08-16 | 2018-02-26 | 주식회사 엠디헬스케어 | 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물 |
| JP2018075036A (ja) * | 2018-02-02 | 2018-05-17 | 株式会社明治 | シトルリン含有発酵乳およびその製造方法 |
| WO2019188868A1 (ja) * | 2018-03-27 | 2019-10-03 | 森永乳業株式会社 | 抗ストレス用組成物 |
| JP2020039308A (ja) * | 2018-09-12 | 2020-03-19 | キリンホールディングス株式会社 | 労働パフォーマンスの向上用組成物 |
| WO2022196488A1 (ja) * | 2021-03-15 | 2022-09-22 | 森永乳業株式会社 | Ｑｏｌを改善するための組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6153216A (ja) * | 1984-08-23 | 1986-03-17 | Rikagaku Kenkyusho | 高血圧症予防治療剤 |
| JPS61153216A (ja) | 1984-12-27 | 1986-07-11 | Kawasaki Steel Corp | 高炉内への粉体吹き込み方法 |
| US4931430A (en) * | 1987-12-14 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method for preventing or treating anxiety employing an ACE inhibitor |
| JP2855283B2 (ja) * | 1990-04-23 | 1999-02-10 | 株式会社ヤクルト本社 | 抗潰瘍剤およびその製造法 |
| CH683223A5 (fr) | 1991-10-25 | 1994-02-15 | Nestle Sa | Procédé de préparation d'un lait acidifié. |
| JP2782142B2 (ja) * | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
| FR2703219B1 (fr) * | 1993-04-01 | 1995-05-05 | Abram Cala | Le pain fait au kéfir. |
| KR960009004B1 (ko) * | 1993-09-01 | 1996-07-10 | 안기영 | 셀레늄 함유 유산균 식품 및 그의 제조방법 |
| JP2824821B2 (ja) * | 1993-11-04 | 1998-11-18 | カルピス株式会社 | 乳酸菌及び発酵乳製品 |
| DE4411108A1 (de) * | 1994-03-30 | 1995-10-05 | Basf Ag | Verwendung von fermentativ erhaltenen Milchprodukten zur Behandlung von Hauterkrankungen |
| JP2855078B2 (ja) * | 1994-08-16 | 1999-02-10 | 雪印乳業株式会社 | ケフィール様発酵乳とその製造方法 |
-
1996
- 1996-08-07 JP JP20850496A patent/JP4065038B2/ja not_active Expired - Lifetime
-
1997
- 1997-08-06 SK SK145-99A patent/SK285323B6/sk not_active IP Right Cessation
- 1997-08-06 AR ARP970103564A patent/AR009005A1/es not_active Application Discontinuation
- 1997-08-06 CN CN97198594A patent/CN1112931C/zh not_active Expired - Fee Related
- 1997-08-06 WO PCT/JP1997/002728 patent/WO1998005343A1/ja active IP Right Grant
- 1997-08-06 PT PT97934703T patent/PT966969E/pt unknown
- 1997-08-06 TW TW086111250A patent/TW445136B/zh not_active IP Right Cessation
- 1997-08-06 ES ES97934703T patent/ES2239784T3/es not_active Expired - Lifetime
- 1997-08-06 CA CA002262652A patent/CA2262652C/en not_active Expired - Fee Related
- 1997-08-06 CZ CZ0038699A patent/CZ299912B6/cs not_active IP Right Cessation
- 1997-08-06 DE DE69733215T patent/DE69733215T2/de not_active Expired - Lifetime
- 1997-08-06 TR TR1999/00233T patent/TR199900233T2/xx unknown
- 1997-08-06 US US09/242,239 patent/US6596301B1/en not_active Expired - Fee Related
- 1997-08-06 MX MXPA99001203A patent/MXPA99001203A/es not_active IP Right Cessation
- 1997-08-06 AU AU37828/97A patent/AU719204B2/en not_active Ceased
- 1997-08-06 ZA ZA976989A patent/ZA976989B/xx unknown
- 1997-08-06 BR BR9711126-0A patent/BR9711126A/pt not_active Application Discontinuation
- 1997-08-06 KR KR1019997001032A patent/KR100331141B1/ko not_active IP Right Cessation
- 1997-08-06 MY MYPI97003590A patent/MY124559A/en unknown
- 1997-08-06 EP EP97934703A patent/EP0966969B1/en not_active Expired - Lifetime
- 1997-08-06 AT AT97934703T patent/ATE294586T1/de active
- 1997-08-07 ID IDP972738A patent/ID19984A/id unknown
-
1999
- 1999-03-05 BG BG103228A patent/BG63074B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0966969A1 (en) | 1999-12-29 |
| US6596301B1 (en) | 2003-07-22 |
| TR199900233T2 (xx) | 1999-06-21 |
| MXPA99001203A (es) | 2004-11-22 |
| SK285323B6 (sk) | 2006-11-03 |
| JPH1045610A (ja) | 1998-02-17 |
| KR20000029867A (ko) | 2000-05-25 |
| CZ299912B6 (cs) | 2008-12-29 |
| AU3782897A (en) | 1998-02-25 |
| ATE294586T1 (de) | 2005-05-15 |
| CA2262652C (en) | 2004-02-10 |
| EP0966969B1 (en) | 2005-05-04 |
| CZ38699A3 (cs) | 1999-07-14 |
| DE69733215D1 (de) | 2005-06-09 |
| JP4065038B2 (ja) | 2008-03-19 |
| CA2262652A1 (en) | 1998-02-12 |
| ZA976989B (en) | 1999-05-06 |
| BG103228A (en) | 2000-05-31 |
| EP0966969A4 (en) | 2000-04-26 |
| BR9711126A (pt) | 2000-01-11 |
| WO1998005343A1 (fr) | 1998-02-12 |
| TW445136B (en) | 2001-07-11 |
| CN1232400A (zh) | 1999-10-20 |
| KR100331141B1 (ko) | 2002-04-01 |
| SK14599A3 (en) | 2000-03-13 |
| AR009005A1 (es) | 2000-03-08 |
| ES2239784T3 (es) | 2005-10-01 |
| ID19984A (id) | 1998-09-03 |
| MY124559A (en) | 2006-06-30 |
| DE69733215T2 (de) | 2006-02-16 |
| PT966969E (pt) | 2005-08-31 |
| AU719204B2 (en) | 2000-05-04 |
| CN1112931C (zh) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG63074B1 (bg) | Лекарства против стрес и функционални храни притежаващи противостресови ефекти | |
| HU228050B1 (en) | Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain | |
| EP1085816B1 (en) | Dietary supplement derived from fermented milks for the prevention of osteoporosis | |
| TW200533299A (en) | Functional food for improving endogenous rhythm of melatonin secretion, and functional food for improving circadian rhythm | |
| CN106212675A (zh) | 一种茶味风味发酵乳及其制备方法 | |
| JP3784045B2 (ja) | Ｌｄｌ酸化抑制飲食品及び医薬品 | |
| JP2023096136A (ja) | 労働パフォーマンスの向上用組成物 | |
| BR112021010794A2 (pt) | Probióticos para a saúde cognitiva e mental | |
| US20190167622A1 (en) | Citrulline-containing fermented milk and method for producing same | |
| JP5679966B2 (ja) | 皮膚機能改善組成物 | |
| CN108720024A (zh) | 一种活性多酶维生素细胞营养液 | |
| US20200360451A1 (en) | Fermented milk for improving autonomic function | |
| RU2813883C1 (ru) | Способ производства простокваши | |
| PL190433B1 (pl) | Zastosowanie fermentowanego kwaśnego mleka do wyttaaarzania środka lub produktu żywnościowego zapobiegającego lub łagodzącego objawy stresu | |
| JP4435882B2 (ja) | アルコール吸収抑制組成物 | |
| EP2604123A1 (en) | Method and nutritional compositions for the treatment of diarrhea. | |
| US20240245087A1 (en) | Fermented Camel Milk with Propolis-Engineered Probiotic for Treating Adverse Bowel Disorders | |
| JP2006069940A (ja) | ストレス由来の皮膚血流低下改善用組成物、皮膚機能改善用組成物およびそれらを用いた飲食品 | |
| RU2039445C1 (ru) | Способ получения ферментированного продукта из пахты | |
| Olusola et al. | CPQ Nutrition (2018) 3: 2 Research Article | |
| JP2023157809A (ja) | 睡眠改善剤 | |
| Glickstein | A study of iodization and buddeization on the enzymes, bacterial content, physical and chemical properties, and nutritional value of milk | |
| KR20010105720A (ko) | 산양유를 포함하는 성기능 장애 예방 및 치료용 식품 조성물 | |
| MXPA00012300A (en) | Dietary supplement derived from fermented milks for the prevention of osteoporosis | |
| BE725166A (ko) |